| Pharmaceutical active ingredients: |
| Norepinephrine |
| Available forms, composition and doses of Adronis: |
| Injectable; Injection; Norepinephrine 2 mg / ml |
| Adronis medical category: |
| Human:Alpha- and beta-adrenergic agonistsCardiovascular drugsVasoconstrictors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01CA03 - Norepinephrine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Neiss Labs |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Adrocil | Trifluridine | Edol |
| Adro-Derm | 1-Propanol; Alcohol; Chlorhexidine Gluconate | Adroka |
| Adrome | Carbazochrome Sodium Sulfonate | Landson |
| Adro-Med | Soap Substitute | Adroka |
| Adronat | Alendronic Acid (Alendronate Sodium) | Neopharmed; Tecnifar |
| Adrop | Epinephrine | Unidentified Pharmaceutical Company |
| Adrosal | Doxorubicin Hydrochloride | Naprod Life Sciences; Ambica International Trading Corporation; Sherryville Medical & Healthcare Products; VHB Pharmaceuticals |
| Adrovance | Alendronic Acid (Alendronate Sodium); Vitamin D3 (Cholecalciferol) | Beaufour Ipsen; Vianex |
| Adrover | Hexylresorcinol | Unidentified Pharmaceutical Company |
| Adrovit Capsules | Lycopene; Selenium (Selenium Dioxide); Vitamin A; Vitamin C; Vitamin E (Alpha Tocopherol); Zinc Sulfate | Adley Formulation |